Fsd Pharma Class Stock Working Capital
| HUGEDelisted Stock | USD 0.09 0 4.56% |
FSD Pharma Class fundamentals help investors to digest information that contributes to FSD Pharma's financial success or failures. It also enables traders to predict the movement of FSD Stock. The fundamental analysis module provides a way to measure FSD Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FSD Pharma stock.
FSD |
FSD Pharma Class Company Working Capital Analysis
FSD Pharma's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current FSD Pharma Working Capital | 6.52 M |
Most of FSD Pharma's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FSD Pharma Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionAccording to the company's disclosures, FSD Pharma Class has a Working Capital of 6.52 M. This is 98.47% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The working capital for all United States stocks is 99.56% higher than that of the company.
FSD Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FSD Pharma's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FSD Pharma could also be used in its relative valuation, which is a method of valuing FSD Pharma by comparing valuation metrics of similar companies.FSD Pharma is currently under evaluation in working capital category among its peers.
FSD Fundamentals
| Return On Equity | -0.64 | |||
| Return On Asset | -0.34 | |||
| Current Valuation | 4.57 M | |||
| Shares Outstanding | 46.06 M | |||
| Shares Owned By Insiders | 9.74 % | |||
| Shares Owned By Institutions | 2.81 % | |||
| Number Of Shares Shorted | 176.97 K | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 91.86 X | |||
| Gross Profit | (3.33 M) | |||
| EBITDA | (17.38 M) | |||
| Net Income | (18.56 M) | |||
| Cash And Equivalents | 31.62 M | |||
| Cash Per Share | 0.83 X | |||
| Total Debt | 337.46 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 3.98 X | |||
| Book Value Per Share | 0.30 X | |||
| Cash Flow From Operations | (11.03 M) | |||
| Short Ratio | 0.11 X | |||
| Earnings Per Share | (0.25) X | |||
| Target Price | 2.6 | |||
| Number Of Employees | 10 | |||
| Beta | 0.85 | |||
| Market Capitalization | 4.65 M | |||
| Total Asset | 17.39 M | |||
| Retained Earnings | (157.1 M) | |||
| Working Capital | 6.52 M | |||
| Current Asset | 3 M | |||
| Current Liabilities | 13 M | |||
| Net Asset | 17.39 M |
About FSD Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FSD Pharma Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FSD Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FSD Pharma Class based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |